SENORES

Senores Pharmaceuticals has reached a significant milestone by hitting a new 52-week high of Rs. 755 on October 16, 2025. This marks a notable achievement for the small-cap company in the Pharmaceuticals and Biotechnology sector. The stock has shown strong performance, outperforming its sector by 3.8% today. In the past two days, Senores Pharmaceuticals has experienced a consecutive gain, rising by 4.3%. During today's trading session, the stock touched an intraday high of Rs. 755, reflecting a 4.96% increase. Additionally, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend. The broader market is also experiencing positive momentum, with the Sensex climbing 253.56 points to reach 83,048.35, just 1.27% away from its own 52-week high. Overall, the performance of Senores Pharmaceuticals stands out in a bullish market environment.